Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show all 35 disclosures

REDUCEDStale
Paolini John F.
Kiniksa Pharmaceuticals Intl · NASDAQ
−4,029 sh · $319.4K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
+3,932 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Ragosa Mark
Kiniksa Pharmaceuticals Intl · NASDAQ
+1,591 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Patel Sanj K
Kiniksa Pharmaceuticals Intl · NASDAQ
+8,609 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Patel Sanj K
Kiniksa Pharmaceuticals Intl · NASDAQ
+6,481 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Moat Ross
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,477 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
−4,600 sh · $369.4K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Paolini John F.
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,497 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,362 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
+279 sh · $9.3K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Moat Ross
Kiniksa Pharmaceuticals Intl · NASDAQ
−4,007 sh · $317.7K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Paolini John F.
Kiniksa Pharmaceuticals Intl · NASDAQ
+1,750 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Moat Ross
Kiniksa Pharmaceuticals Intl · NASDAQ
+1,740 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Ragosa Mark
Kiniksa Pharmaceuticals Intl · NASDAQ
−4,404 sh · $349.1K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Paolini John F.
Kiniksa Pharmaceuticals Intl · NASDAQ
+1,624 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Patel Sanj K
Kiniksa Pharmaceuticals Intl · NASDAQ
+9,991 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
−5,531 sh · $438.5K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,558 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Ragosa Mark
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,694 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Megna Michael R
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,644 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Paolini John F.
Kiniksa Pharmaceuticals Intl · NASDAQ
+2,457 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Moat Ross
Kiniksa Pharmaceuticals Intl · NASDAQ
+1,611 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Quart Barry D
Kiniksa Pharmaceuticals Intl · NASDAQ
−2,600 sh
Filed 21 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Kiniksa Pharmaceuticals Intl · NASDAQ
420,914 sh · $20.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Kiniksa Pharmaceuticals Intl · NASDAQ
4,591,136 sh · $85.7M
Filed 30 Jun 2024SEC 13Fview source